These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15540537)

  • 1. [Cardiovascular risk in diabetes--diagnostic and therapeutic aspects].
    Schnell O; Standl E
    MMW Fortschr Med; 2004 Sep; 146(35-36):36-8. PubMed ID: 15540537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of acute coronary syndromes.
    Schulman SP; Fessler HE
    Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction.
    Exaire JE; Fathi RB; Brener SJ; Karha J; Ellis SG; Bhatt DL
    Arch Cardiol Mex; 2006; 76(4):376-82. PubMed ID: 17315613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
    Mehilli J; Kastrati A; Schühlen H; Dibra A; Dotzer F; von Beckerath N; Bollwein H; Pache J; Dirschinger J; Berger PP; Schömig A;
    Circulation; 2004 Dec; 110(24):3627-35. PubMed ID: 15531766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
    Scheller B; Hennen B; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
    [No Abstract]   [Full Text] [Related]  

  • 6. [From risk factors to symptomatic coronary artery disease. Update cardiology 2001/2002--part I].
    Fries R; Böhm M
    Med Klin (Munich); 2003 Apr; 98(4):218-25. PubMed ID: 12715145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy for ischemic heart disease.
    Lange RA; Hillis LD
    N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308
    [No Abstract]   [Full Text] [Related]  

  • 8. [New antiaggregants and their importance for the practitioner].
    Tsakiris DA
    Ther Umsch; 2003 Jan; 60(1):24-6. PubMed ID: 12638474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
    Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL
    JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary use of antiplatelet therapies in percutaneous coronary interventions.
    Saw J; Moliterno DJ
    Coron Artery Dis; 2003 Aug; 14(5):373-80. PubMed ID: 12878902
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of platelet surface receptors and early changes in platelet function in patients with STEMI treated with abciximab and clopidogrel versus clopidogrel alone.
    Konopka A; Spychalska J; Sitkiewicz D; Zdebska E; Pilichowska I; Piotrowski W; Stepińska J
    Am J Cardiovasc Drugs; 2007; 7(6):433-9. PubMed ID: 18076210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary syndromes in the elderly].
    Bounhoure JP; Carrié D; Puel J
    Bull Acad Natl Med; 2006; 190(4-5):807-16; discussion 816, 873-6. PubMed ID: 17195608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of angioplasty with stenting in acute myocardial infarction.
    Herrmann HC
    N Engl J Med; 2002 Aug; 347(5):367-8; author reply 367-8. PubMed ID: 12151478
    [No Abstract]   [Full Text] [Related]  

  • 14. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
    Mehta SR;
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on adjunctive pharmacotherapy to improve outcomes of percutaneous coronary intervention.
    Kereiakes DJ
    J Invasive Cardiol; 2009 Mar; 21(3):110-3. PubMed ID: 19258641
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
    Gurm HS; Lincoff AM; Lee D; Tang WH; Jia G; Booth JE; Califf RM; Ohman EM; Van de Werf F; Armstrong PW; Guetta V; Wilcox R; Topol EJ;
    J Am Coll Cardiol; 2004 Feb; 43(4):542-8. PubMed ID: 14975461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel under scrutiny.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):925-6. PubMed ID: 19016464
    [No Abstract]   [Full Text] [Related]  

  • 18. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
    Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are stenting and glycoprotein IIb/IIIa blockade of good value in primary percutaneous coronary intervention?
    Cole JH; Weintraub WS
    Circulation; 2003 Dec; 108(23):2831-3. PubMed ID: 14662689
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antithrombotic treatment of acute coronary syndromes without ST-segment elevation].
    Radke PW; Schunkert H
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S204-7. PubMed ID: 17109249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.